An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An integrated proteomic approach to identifying circulating biomarkers in high-risk neuroblastoma and their potential in relapse monitoring

Published:2011-09-07 Issue:9-10 Volume:5 Page:532-541
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Egler Rachel A.,Li Yiting,Dang Tu Anh T.,Peters Tricia L.,Leung Eastwood,Huang Shixia,Russell Heidi V.,Liu Hao,Man Tsz-Kwong

Funder

Neuroblastoma Program at Texas Children's Cancer and Hematology Center

National Cancer Institute

Publisher

Wiley

Subject

Clinical Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/prca.201000089/fullpdf

Reference38 articles.

1. Neuroblastoma;Maris;Lancet,2007

2. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study;Matthay;J. Clin. Oncol.,1998

3. Neuroblastoma: a single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors;Lau;Pediatr. Hematol. Oncol.,2002

4. The biologic basis for neuroblastoma heterogeneity and risk stratification;Maris;Curr. Opin. Pediatr.,2005

5. Factors influencing survival in children with recurrent neuroblastoma;Lau;J. Pediatr. Hematol. Oncol.,2004

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma;Frontiers in Endocrinology;2022-07-26

2. Monitoring Immune Responses in Neuroblastoma Patients during Therapy;Cancers;2020-02-24

3. Biochemical testing for neuroblastoma using plasma free 3‐O‐methyldopa, 3‐methoxytyramine, and normetanephrine;Pediatric Blood & Cancer;2019-11-14

4. Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer;Cancers;2019-08-01

5. A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931;Frontiers in Immunology;2018-06-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3